Position in ZTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$18,139,545
-$24,257,532 QoQ
Shares Held
252,429
-29.6% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#166
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $141,737,028 across 29 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
2,604,559 | $24,300,533 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,826,234 | $18,262,340 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
252,429 | $18,139,545 | |
| 4 | VTRS |
Viatris Inc
|
924,858 | $14,686,743 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
722,863 | $11,587,493 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
317,401 | $7,811,236 | |
| 7 | HROW |
Harrow, Inc.
|
180,893 | $7,682,525 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
198,546 | $6,726,737 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,139,545 | 252,429 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $42,397,077 | 358,659 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $67,640,199 | 537,595 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $98,635,041 | 674,105 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $110,060,774 | 705,744 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $119,908,501 | 728,263 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $112,937,533 | 693,166 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $139,720,925 | 715,124 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $120,990,194 | 697,913 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $147,897,320 | 874,046 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $161,372,473 | 817,614 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $130,205,063 | 748,391 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $119,848,341 | 695,943 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $89,577,006 | 538,194 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $60,813,118 | 414,965 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $60,709,923 | 409,400 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $68,536,837 | 398,725 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $75,537,835 | 400,540 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $95,427,684 | 391,049 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $74,108,475 | 381,727 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $71,044,901 | 381,224 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $65,898,449 | 418,456 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $65,150,729 | 393,660 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $62,010,769 | 374,982 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $44,915,815 | 327,757 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $35,824,127 | 304,394 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||